GAITHERSBURG, Md., Nov. 10, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a...
GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT, MXCN) is a...
GAITHERSBURG, Md., Oct. 29, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a...
SOUTH SAN FRANCISCO and GAITHERSBURG, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT;...
GAITHERSBURG, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a...
GAITHERSBURG, Md., Sept. 17, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a...
GAITHERSBURG, Md., Sept. 13, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a...
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology Agreement represents MaxCyte's 14th strategic platform license (SPL) Sana...
DLA Piper advises underwriters of MaxCyte's upsized US IPO PR Newswire NEW YORK, July 30, 2021 NEW YORK, July 30, 2021 /PRNewswire/ -- DLA Piper...
MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market PR Newswire GAITHERSBURG, Md., July 30...
MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market This...
MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market This announcement contains inside information PR...
Financial information in the Form S-1 registration statement and Change to Board of Directors PR Newswire GAITHERSBURG, Md., July 12, 2021...
Proposed Dual-Listing on Nasdaq This announcement contains inside information PR Newswire GAITHERSBURG, Md...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.